The company has contracted with a urologist, who will review customers' requests for tests, and prescribe the firm's epigenetics-based male fertility analysis.
Xifin customers will be able to access lab services in support of consumer-initiated testing and employer-based screening programs, as part of the deal.
The company, which has offices in Italy and New York, outsources the analysis to partner laboratories and offers genetic counseling as an option.
The re-emergence of direct-to-consumer genetic health risk tests has healthcare providers worried once again about their impact and utility.
The firm said that the service provides analysis of fitness and health by measuring the body's internal markers at a time of increasing uptake for external health tracking devices.
Genomed, based in Warsaw, offers sequencing-based diagnostic and research services and brought BGI's noninvasive prenatal NIFTY test in house last year.